Arkolith/Insider Trading/ADPT/Form 4

Robins Harlan S

Chief Scientific OfficerAdaptive Biotechnologies Corp (ADPT) · full profile →Form 4 · filed Jul 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8.5M
Net Open-Market Flow
-$8.5M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2026Sell(S)239K$21.74$5.2M1.2M
Jul 2, 2026Sell(S)147K$22.45$3.3M1.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780851-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML